Anat Erdreich-Epstein

Anat Erdreich-Epstein

Auto-generated profile, based on publicly available information

Anat Erdreich-Epstein

Children’s Hospital Los Angeles and the Keck School of Medicine, University of Southern California

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Cancer Cell
Verified
Journal Article
Closed access
JTJonathon Torchia
Jonathon Torchia
BGBrian Golbourn
Brian Golbourn
SFShengrui Feng
Shengrui Feng
KHKing Ching Ho
King Ching Ho
PSPatrick Sin-Chan
Patrick Sin-Chan
AHAnnie Huang
Annie Huang

15 August 2003 in Blood
Verified
Journal Article
Open access
NPNatalya Perelman
Natalya Perelman
SSSuresh K. Selvaraj
Suresh K. Selvaraj
SBSandeep Batra
Sandeep Batra
LLLori R. Luck
Lori R. Luck
AEAnat Erdreich-Epstein
Anat Erdreich-Epstein
PMPunam Malik
Punam Malik
Sickle cell disease (SCD) results in chronic hypoxia and secondarily increased erythropoietin concentrations. Leukocytosis and activated monocytes are also observed in SCD in absence of infection or vaso-occlusion (steady state), the reasons for which are unknown. We found that erythroid cells produced placenta growth factor (PlGF), an angiogenic growth factor belonging to the vascular endothelial growth factor (VEGF) family, and its expression was induced in bone marrow CD34+ progenitor cells in the presence of erythropoietin. Furthermore, the steady state circulating PlGF levels in subjects with severe SCD (at least 3 vaso-occlusive crises [VOCs] per year) were 18.5 ± 1.2 pg/mL (n = 9) compared with 15.5 ± 1.2 pg/mL (n = 13) in those with mild SCD (fewer than 3 VOCs per year) and 11.3 ± 0.7 pg/mL (n = 9) in healthy controls (P < .05), suggesting a correlation between PlGF levels and SCD severity. In addition, PlGF significantly increased mRNA levels of the proinflammatory cytochemokines interleukin-1β, interleukin-8, monocyte chemoattractant protein-1, and VEGF in peripheral blood mononuclear cells (MNCs) of healthy subjects (n = 4; P < .05). Expression of these same cytochemokines was significantly increased in MNCs from subjects with SCD at steady state (n = 14), compared with healthy controls. Of the leukocyte subfractions, PlGF stimulated monocyte chemotaxis (P < .05, n = 3). Taken together, these data show for the first time that erythroid cells intrinsically release a factor that can directly activate monocytes to increase inflammation. The baseline inflammation seen in SCD has always been attributed to sequelae secondary to the sickling phenomenon. We show that PlGF contributes to the inflammation observed in SCD and increases the incidence of vaso-occlusive events.

12 March 2015 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
AMAshley S. Margol
Ashley S. Margol
NRNathan J. Robison
Nathan J. Robison
JGJanahan Gnanachandran
Janahan Gnanachandran
LHLong T. Hung
Long T. Hung
RKRebekah J. Kennedy
Rebekah J. Kennedy
SAShahab Asgharzadeh
Shahab Asgharzadeh
Purpose: Medulloblastoma in children can be categorized into at least four molecular subgroups, offering the potential for targeted therapeutic approaches to reduce treatment-related morbidities. Little is known about the role of tumor microenvironment in medulloblastoma or its contribution to these molecular subgroups. Tumor microenvironment has been shown to be an important source for therapeutic targets in both adult and pediatric neoplasms. In this study, we investigated the hypothesis that expression of genes related to tumor-associated macrophages (TAM) correlates with the medulloblastoma molecular subgroups and contributes to a diagnostic signature. Methods: Gene-expression profiling using human exon array (n = 168) was analyzed to identify medulloblastoma molecular subgroups and expression of inflammation-related genes. Expression of 45 tumor-related and inflammation-related genes was analyzed in 83 medulloblastoma samples to build a gene signature predictive of molecular subgroups. TAMs in medulloblastomas (n = 54) comprising the four molecular subgroups were assessed by immunohistochemistry (IHC). Results: A 31-gene medulloblastoma subgroup classification score inclusive of TAM-related genes (CD163 and CSF1R) was developed with a misclassification rate of 2%. Tumors in the Sonic Hedgehog (SHH) subgroup had increased expression of inflammation-related genes and significantly higher infiltration of TAMs than tumors in the Group 3 or Group 4 subgroups (P < 0.0001 and P < 0.0001, respectively). IHC data revealed a strong association between location of TAMs and proliferating tumor cells. Conclusions: These data show that SHH tumors have a unique tumor microenvironment among medulloblastoma subgroups. The interactions of TAMs and SHH medulloblastoma cells may contribute to tumor growth revealing TAMs as a potential therapeutic target. Clin Cancer Res; 21(6); 1457–65. ©2014 AACR.

23 March 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
GXGuosheng Xiong
Guosheng Xiong
Mohamed I. HusseinyMohamed I. Husseiny
Mohamed I. Husseiny
LSLiping Song
Liping Song
AEAnat Erdreich‐Epstein
Anat Erdreich‐Epstein
GSGregory M. Shackleford
Gregory M. Shackleford
LMLeonid S. Metelitsa
Leonid S. Metelitsa
Although tumors express potentially immunogenic tumor‐associated antigens (TAAs), cancer vaccines often fail because of inadequate antigen delivery and/or insufficient activation of innate immunity. Engineering nonpathogenic bacterial vectors to deliver TAAs of choice may provide an efficient way of presenting TAAs in an immunogenic form. In this study, we used genes of Salmonella pathogenicity island 2 (SPI2) to construct a novel cancer vaccine in which a TAA, survivin, was fused to SseF effector protein and placed under control of SsrB, the central regulator of SPI2 gene expression. This construct uses the type III secretion system (T3SS) of Salmonella and allows preferential delivery of tumor antigen into the cytosol of antigen‐presenting cells for optimal immunogenicity. In a screen of a panel of attenuated strains of Salmonella, we found that a double attenuated strain of Salmonella typhimurium, MvP728 (purD/htrA), was not toxic to mice and effectively expressed and translocated survivin protein inside the cytosol of murine macrophages. We also found that a ligand for CD1d‐reactive natural killer T (NKT) cells, α‐glucuronosylceramide (GSL1), enhanced MvP728‐induced interleukin‐12 production in human dendritic cells and that in vivo coadministration of a NKT ligand with MvP728‐Llo or MvP728‐survivin enhanced effector‐memory cytotoxic T lymphocyte (CTL) responses. Furthermore, combined use of MvP728‐survivin with GSL1 produced antitumor activity in mouse models of CT26 colon carcinoma and orthotopic DBT glioblastoma. Therefore, the use of TAA delivery via SPI‐2‐regulated T3SS of Salmonella and NKT ligands as adjuvants may provide a foundation for new cancer vaccines.

11 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
VYViveka Nand Yadav
Viveka Nand Yadav
DZDaniel Zamler
Daniel Zamler
GBGregory J. Baker
Gregory J. Baker
PKPadma Kadiyala
Padma Kadiyala
AEAnat Erdreich-Epstein
Anat Erdreich-Epstein
PLPedro R. Lowenstein
Pedro R. Lowenstein
CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study

11 October 2011 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
AGAlexa E. Gozali
Alexa E. Gozali
BBBarbara Britt
Barbara Britt
LSLisa Shane
Lisa Shane
IGIgnacio Gonzalez
Ignacio Gonzalez
FGFloyd Gilles
Floyd Gilles
JFJonathan L. Finlay
Jonathan L. Finlay